79 related articles for article (PubMed ID: 7667816)
1. Use of a low-molecular weight heparin (enoxaparin) or of a phenformin-like substance (moroxydine chloride) in primary early recurrent aborters with an impaired fibrinolytic capacity.
Gris JC; Neveu S; Tailland ML; Courtieu C; Marès P; Schved JF
Thromb Haemost; 1995 Mar; 73(3):362-7. PubMed ID: 7667816
[TBL] [Abstract][Full Text] [Related]
2. Plasma fibrinolytic activators and their inhibitors in women suffering from early recurrent abortion of unknown etiology.
Gris JC; Neveu S; Mares P; Biron C; Hedon B; Schved JF
J Lab Clin Med; 1993 Nov; 122(5):606-15. PubMed ID: 8228580
[TBL] [Abstract][Full Text] [Related]
3. Prospective study of a phenformin-like substance (moroxydine chloride) in patients with deficient vessel wall fibrinolysis.
Tengborn L; Hedner U; Nilsson IM
J Med; 1982; 13(5-6):353-64. PubMed ID: 6963328
[TBL] [Abstract][Full Text] [Related]
4. Gestational outcome in thrombophilic women with recurrent pregnancy loss treated by enoxaparin.
Brenner B; Hoffman R; Blumenfeld Z; Weiner Z; Younis JS
Thromb Haemost; 2000 May; 83(5):693-7. PubMed ID: 10823264
[TBL] [Abstract][Full Text] [Related]
5. Enoxaparin-metformin and enoxaparin alone may safely reduce pregnancy loss.
Ramidi G; Khan N; Glueck CJ; Wang P; Goldenberg N
Transl Res; 2009 Jan; 153(1):33-43. PubMed ID: 19100956
[TBL] [Abstract][Full Text] [Related]
6. Tissue-type plasminogen activator after venous occlusion in pregnancy and puerperium.
Stegnar M; Zore A; Novak-Antolic Z; Vovk N; Kruithof EK
Thromb Haemost; 1993 Sep; 70(3):486-90. PubMed ID: 8259554
[TBL] [Abstract][Full Text] [Related]
7. [Treatment with enoxaparin adapted to the fertility programs in women with recurrent abortion and thrombophilia].
Sarto A; Rocha M; Geller M; Capmany C; Martínez M; Quintans C; Donaldson M; Pasqualini RS
Medicina (B Aires); 2001; 61(4):406-12. PubMed ID: 11563168
[TBL] [Abstract][Full Text] [Related]
8. Respective evaluation of the prevalence of haemostasis abnormalities in unexplained primary early recurrent miscarriages. The Nimes Obstetricians and Haematologists (NOHA) Study.
Gris JC; Ripart-Neveu S; Maugard C; Tailland ML; Brun S; Courtieu C; Biron C; Hoffet M; Hédon B; Marès P
Thromb Haemost; 1997 Jun; 77(6):1096-103. PubMed ID: 9241739
[TBL] [Abstract][Full Text] [Related]
9. Thromboprophylaxis for recurrent miscarriage in women with or without thrombophilia. HABENOX: a randomised multicentre trial.
Visser J; Ulander VM; Helmerhorst FM; Lampinen K; Morin-Papunen L; Bloemenkamp KW; Kaaja RJ
Thromb Haemost; 2011 Feb; 105(2):295-301. PubMed ID: 21103659
[TBL] [Abstract][Full Text] [Related]
10. Low-molecular-weight heparin in the treatment of recurrent IVF-ET failure and thrombophilia: a prospective randomized placebo-controlled trial.
Qublan H; Amarin Z; Dabbas M; Farraj AE; Beni-Merei Z; Al-Akash H; Bdoor AN; Nawasreh M; Malkawi S; Diab F; Al-Ahmad N; Balawneh M; Abu-Salim A
Hum Fertil (Camb); 2008 Dec; 11(4):246-53. PubMed ID: 19085261
[TBL] [Abstract][Full Text] [Related]
11. A multicenter randomized double-blind study of enoxaparin compared with unfractionated heparin in the prevention of venous thromboembolic disease in elderly in-patients bedridden for an acute medical illness. The Enoxaparin in Medicine Study Group.
Bergmann JF; Neuhart E
Thromb Haemost; 1996 Oct; 76(4):529-34. PubMed ID: 8902991
[TBL] [Abstract][Full Text] [Related]
12. [Hypofibrinolysis and other hemostatic defects in women with antecedents of early reproductive failure].
Sarto A; Rocha M; Martínez M; Sergio Pasqualini R
Medicina (B Aires); 2000; 60(4):441-7. PubMed ID: 11188948
[TBL] [Abstract][Full Text] [Related]
13. High factor XI, recurrent pregnancy loss, enoxaparin.
Glueck CJ; Pranikoff J; Khan N; Riaz K; Chavan K; Raj P; Umar M; Wang P
Fertil Steril; 2010 Dec; 94(7):2828-31. PubMed ID: 21094629
[TBL] [Abstract][Full Text] [Related]
14. Successful pregnancy outcome in women with bad obstetric history and recurrent fetal loss due to thrombophilia: effect of unfractionated heparin and low-molecular weight heparin.
Ghosh K; Shetty S; Vora S; Salvi V
Clin Appl Thromb Hemost; 2008 Apr; 14(2):174-9. PubMed ID: 18160603
[TBL] [Abstract][Full Text] [Related]
15. Plasma fibrinolytic capacity in renal transplant recipients: effect of steroid-free immunosuppression therapy.
Sartori MT; Rigotti P; Marchini F; Spiezia L; Baldan N; Furian L; Varvarikis C; Girolami A
Transplantation; 2003 Apr; 75(7):994-8. PubMed ID: 12698086
[TBL] [Abstract][Full Text] [Related]
16. Low dose aspirin and low-molecular-weight heparin in the treatment of pregnant Libyan women with recurrent miscarriage.
Elmahashi MO; Elbareg AM; Essadi FM; Ashur BM; Adam I
BMC Res Notes; 2014 Jan; 7():23. PubMed ID: 24405979
[TBL] [Abstract][Full Text] [Related]
17. Antithrombotic prophylaxis during pregnancy in women with deficiency of natural anticoagulants.
Grandone E; De Stefano V; Rossi E; Cappucci F; Colaizzo D; Margaglione M
Blood Coagul Fibrinolysis; 2008 Apr; 19(3):226-30. PubMed ID: 18388503
[TBL] [Abstract][Full Text] [Related]
18. Effects of enoxaparin on late pregnancy complications and neonatal outcome in women with recurrent pregnancy loss and thrombophilia: results from the Live-Enox study.
Brenner B; Bar J; Ellis M; Yarom I; Yohai D; Samueloff A;
Fertil Steril; 2005 Sep; 84(3):770-3. PubMed ID: 16169422
[TBL] [Abstract][Full Text] [Related]
19. Percutaneous coronary intervention in patients receiving enoxaparin or unfractionated heparin after fibrinolytic therapy for ST-segment elevation myocardial infarction in the ExTRACT-TIMI 25 trial.
Gibson CM; Murphy SA; Montalescot G; Morrow DA; Ardissino D; Cohen M; Gulba DC; Kracoff OH; Lewis BS; Roguin N; Antman EM; Braunwald E;
J Am Coll Cardiol; 2007 Jun; 49(23):2238-46. PubMed ID: 17560287
[TBL] [Abstract][Full Text] [Related]
20. [Resistance to activated protein C and pregnancy: thromboprophylaxis with low molecular weight heparin].
Barjot P; Beucher G; Le Querrec A; Derlon-Borel A; Herlicoviez M
J Gynecol Obstet Biol Reprod (Paris); 1999 Oct; 28(6):544-9. PubMed ID: 10598348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
